141 related articles for article (PubMed ID: 758043)
41. [Effect of hormonal therapy on plasma FSH, LH and testosterone levels in prostatic cancer].
Shirai M; Matsuda S; Mitsukawa S; Nakamura M; Yonezawa K
Nihon Hinyokika Gakkai Zasshi; 1975 Feb; 66(2):59-67. PubMed ID: 1168823
[No Abstract] [Full Text] [Related]
42. Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate.
Kumar VL; Wadhwa SN; Kumar V; Farooq A
J Surg Oncol; 1990 Jun; 44(2):122-8. PubMed ID: 1693995
[TBL] [Abstract][Full Text] [Related]
43. Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.
Helmerich D; Altwein JE
Urol Res; 1976 Nov; 4(3):101-5. PubMed ID: 1037036
[TBL] [Abstract][Full Text] [Related]
44. Proceedings: Effect of active immunization against oestradiol-6-bovine serum albumin on circulating levels of oestradiol, testosterone, luteinizing hormone, follicle-stimulating hormone, prolactin and anti-oestradiol tire in the male rat.
Hillier SG; Groom GV; Boyns AR; Cameron EH
J Endocrinol; 1974 May; 61(2):LI-LII. PubMed ID: 4462605
[No Abstract] [Full Text] [Related]
45. Effect of estrogens and progesterone on gonadotropin and prolactin release in a patient with androgen insensitivity.
Nicoletti I; Filipponi P; Fedeli L; Santori PA; Santeusanio F
Obstet Gynecol; 1981 Oct; 58(4):527-32. PubMed ID: 6792578
[TBL] [Abstract][Full Text] [Related]
46. Percutaneous 17 beta-estradiol in treatment of cancer of prostate.
Steg A; Benoit G
Urology; 1979 Oct; 14(4):373-5. PubMed ID: 227153
[TBL] [Abstract][Full Text] [Related]
47. Hyperprolactinemia in cases of infertility and amenorrhea.
Furuhjelm M; Rydner T; Carlström K
Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
[TBL] [Abstract][Full Text] [Related]
48. Effects of ethinyloestradiol on plasma levels of pituitary gonadotrophins, testicular steroids and sex hormone binding globulin in normal men.
Van Look PF; Frölich M
Clin Endocrinol (Oxf); 1981 Mar; 14(3):237-43. PubMed ID: 6790203
[TBL] [Abstract][Full Text] [Related]
49. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
[TBL] [Abstract][Full Text] [Related]
50. Plasma concentrations of pituitary and testicular hormones of fertile and infertile men.
Stanwell-Smith R; Thompson SG; Haines AP; Jeffcoate SL; Hendry WF
Clin Reprod Fertil; 1985 Mar; 3(1):37-48. PubMed ID: 3919915
[TBL] [Abstract][Full Text] [Related]
51. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
Bishop MC; Selby C; Taylor M
Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
[TBL] [Abstract][Full Text] [Related]
52. Effect of chronic administration of estrogen, androgen, or both on serum levels of gonadotropins in adult men.
Sawin CT; Ryan RJ; Longcope C; Fisher LE
J Clin Endocrinol Metab; 1978 Jun; 46(6):911-5. PubMed ID: 122441
[TBL] [Abstract][Full Text] [Related]
53. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
54. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
55. Bromocriptine and oestrogen modulation of gonadotrophin release in normo- and hyperprolactinaemic patients with amenorrhoea.
Djursing J; Hagen C; Christensen F; Nickelsen C
Clin Endocrinol (Oxf); 1981 Aug; 15(2):125-32. PubMed ID: 6796299
[No Abstract] [Full Text] [Related]
56. Evaluation of plasma hormone concentrations in relation to clinical staging in patients with prostatic cancer. British Prostate Study Group.
Br J Urol; 1979 Oct; 51(5):382-9. PubMed ID: 533596
[TBL] [Abstract][Full Text] [Related]
57. Endocrine effects of oestrogen withdrawal in long-term treated patients with prostatic adenocarcinoma.
Tomić R; Damber JE; Bergman B
Eur Urol; 1988; 14(1):6-8. PubMed ID: 3342807
[TBL] [Abstract][Full Text] [Related]
58. [Interdependence between hormonal disorders, staging and degree of malignancy of prostatic gland cancer. 2].
Szymanowski J; Baranowska B; Rozbicka G; Jeske W; Zgliczynski S
J Urol (Paris); 1983; 89(9):663-8. PubMed ID: 6425418
[TBL] [Abstract][Full Text] [Related]
59. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
Daehlin L; Damber JE; von Schoultz B; Bergman B
Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
[TBL] [Abstract][Full Text] [Related]
60. FSH and LH elevation after radiation for treatment of cancer of the prostate.
Seal US
Invest Urol; 1979 Jan; 16(4):278-80. PubMed ID: 429120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
